2018
DOI: 10.1253/circj.cj-16-1324
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Safety of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia

Abstract: the hazard ratio for total CAD increases 1.4-, 1.7-, 2.2-, and 2.8-fold when LDL-C is 2.06-2.57, 2.58-3.09, 3.10-3.61, and ≥3.62 mmol/L, respectively, compared with LDL-C <2.06 mmol/L. 5 Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein secreted primarily by the liver that mediates the transfer of cholesteryl ester (CE) from high-density lipoprotein (HDL) to apolipoprotein (apo)B-rich lipoproteins (Lp; i.e., very-low-density lipoprotein [VLDL] and LDL) in exchange for their triglycerides, as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 23 publications
(21 reference statements)
0
0
0
Order By: Relevance